Remarks of Bill Bogaard
December 11, 2002
PASADENA ENTRETEC SIGNATURE EVENT
GORDON BINDER KEYNOTE SPEAKER
I consider it a privilege to come to the microphone under the auspices of Pasadena Entretec to introduce this morning’s keynote speaker, Gordon Binder, and at the invitation of Stephanie Yanchinski, to offer a few comments on Pasadena’s role as a center for technology based business enterprise, particularly new companies formed to exploit the new fields of learning in the life sciences.
Pasadena Entretec is one indication of what is happening in Pasadena in regard to the establishment of a cluster of technology based companies that find the City of Pasadena a natural and a convenient community in which to do business. I want to compliment Stephanie for the important role that she has created for this new organization to serve as a resource and as a stimulus for new businesses enterprises.
Earlier this year, Pasadena Entretec issued a report on high tech industry in Pasadena and the Pasadena area. What it demonstrates is that there are a significant number of high tech companies operating in the region, offering employment to some 5,000 employees with the potential for doubling that number of high quality employment opportunities as the economy improves.
Pasadena is a center for employment with a diversified local economy, but the numbers of employees involved in high tech companies today are not insignificant in relation to other areas of business activity which are traditional pillars of City revenues and local economic activity.
Even in the face of the uncertain economic climate of the last two years, the high tech business sector is becoming a powerful engine for economic development in the City, and a major source of high quality jobs and innovation.
There’s another important story that should be mentioned relating to the resources available in Pasadena to nurture technology business development. It is a pleasure for me to be associated with the Pasadena Bioscience Center, which during the year 2002 completed its organization as a non-profit organization with a business plan focused for the time being on workforce development of professionals trained to operate immediately and effectively in emerging bioscience enterprises.
PBC was a vision of Senator Jack Scott, who on two occasions over recent years was successful in obtaining seed money funding for analyzing the need for a resource of this kind in the area and for launching PBC as an organization that will offer workforce training, incubator facilities for technology transfer, and potentially other functions that will facilitate our technology based economic sector.
A good beginning has been made, even though we have a long way to go. At present, the Board of PBC consists of the Presidents of three eminent academic institutions that are each committed to developing young people to work in, among other areas, technology based business enterprise: California State University Los Angeles, Pasadena City College, and Cal Poly Pomona. In other words, I have the privilege of serving on the Board with Dr. James Rosser, Dr. James Kossler, and Dr. Robert Suzuki.
Senator Scott continues his role of support as a senior advisor to the Board.
You will be interested to know about the first educational resource that PBC is offering, a workshop series on bioscience product discovery and development. The objective of the ten workshops comprising this series is to give the students an in-depth understanding of the many different interrelated components involved in developing a new bioscience product. The workshop topics include
Finance and Economics
Marketing and Sales
I can say that the series is doing very well with over 35 committed students, most with significant prior work experience who are engaged in taking full advantage of the sessions being offered in this workshop series.
Well, perhaps I have talked enough about the general plan for technology based business activity in our region. I can say that our keynote speaker today is evidence of the importance of our newly emerging business area.
Gordon Binder was instrumental in steering Amgen, Inc. through a key period in its history, and is currently involved in an exciting new venture, an investment fund focusing on life sciences.
Mr. Binder joined Amgen in 1982 as Chief Financial Officer, and became CEO in October, 1988. In the year 2000, he retired as CEO and became Chairman of the Board.
The following year, with Amgen’s former Vice President of Research, he started a new venture capital firm, Coastview Capital. In addition, he is a former Chairman of the Pharmaceutical Research and Manufacturers of America, and former Chairman of the Biotechnology Industry Association. He serves on the boards of MIT, Caltech, and the American Enterprise Institute.
Mr. Binder received his Bachelors degree in electrical engineering from Purdue University, and his MBA from Harvard. He and his wife, Adele, live in Holmby Hills, and they have two sons, Brant and Todd.
It is a distinct pleasure for me, and I think a privilege for us all, to welcome Gordon Binder as the keynote speaker at this Entretec Signature Event.